We developed a nomogram model to predict the occurrence of PCII in patients with brain tumors, facilitating the assessment of PCII risk in this patient population.
Yu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: